{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:31:22Z","timestamp":1790695882619,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006768","name":"Taiyuan University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ASTRA 2014-2020.4.01.16-0032"],"award-info":[{"award-number":["ASTRA 2014-2020.4.01.16-0032"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003510","name":"Haridus- ja Teadusministeerium","doi-asserted-by":"publisher","award":["IUT 19\u20139"],"award-info":[{"award-number":["IUT 19\u20139"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbrc.2019.08.130","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T08:04:32Z","timestamp":1567152272000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach"],"prefix":"10.1016","volume":"519","author":[{"given":"Mart","family":"Reimund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Risti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sviridov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aivar","family":"Lookene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.08.130_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2019.08.130_bib2","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2019.08.130_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2018.2866","article-title":"Association of genetically enhanced lipoprotein lipase\u2013mediated lipolysis and low-density lipoprotein cholesterol\u2013lowering alleles with risk of coronary disease and type 2 diabetes","volume":"3","author":"Lotta","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbrc.2019.08.130_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2019.08.130_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","article-title":"A\u00a0review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease","volume":"61","author":"Kei","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2019.08.130_bib6","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/bi00733a026","article-title":"Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources","volume":"12","author":"Havel","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2019.08.130_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1194\/jlr.D071787","article-title":"Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry","volume":"58","author":"Reimund","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2019.08.130_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.114.220418","article-title":"A\u00a0novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice","volume":"352","author":"Amar","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2019.08.130_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI108753","article-title":"Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects","volume":"60","author":"Kashyap","year":"1977","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.08.130_bib10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI117151","article-title":"Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice","volume":"93","author":"Shachter","year":"1994","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.08.130_bib11","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1210\/jc.2016-3903","article-title":"A\u00a0novel APOC2 missense mutation causing apolipoprotein C-II deficiency with severe triglyceridemia and pancreatitis","volume":"102","author":"Ueda","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2019.08.130_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOL.0000000000000297","article-title":"Role of lipoprotein lipase in lipid metabolism","volume":"27","author":"Olivecrona","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2019.08.130_bib13","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M900145-JLR200","article-title":"GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4","volume":"50","author":"Sonnenburg","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2019.08.130_bib14","doi-asserted-by":"crossref","first-page":"13919","DOI":"10.1074\/jbc.M114.634626","article-title":"Evidence for two distinct binding sites for lipoprotein lipase on glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1)","volume":"290","author":"Reimund","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.08.130_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbrc.2019.08.130_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.115.229740","article-title":"Creation of apolipoprotein C-II (ApoC-II) mutant mice and correction of their hypertriglyceridemia with an ApoC-II mimetic peptide","volume":"356","author":"Sakurai","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2019.08.130_bib17","article-title":"Apolipoprotein C-II mimetic peptide promotes the plasma clearance of triglyceride-rich lipid emulsion and the incorporation of fatty acids into peripheral tissues of mice","volume":"2019","author":"Komatsu","year":"2019","journal-title":"J.\u00a0Nutr. Metab."},{"key":"10.1016\/j.bbrc.2019.08.130_bib18","first-page":"989","article-title":"Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia","volume":"8","author":"Liu","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbrc.2019.08.130_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0968-0004(01)01938-7","article-title":"Macromolecular crowding: obvious but underappreciated","volume":"26","author":"Ellis","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2019.08.130_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cmet.2015.02.004","article-title":"A\u00a0liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice","volume":"21","author":"Li","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2019.08.130_bib21","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0022-2275(20)36948-0","article-title":"Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins","volume":"34","author":"Vilella","year":"1993","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2019.08.130_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2016.06.020","article-title":"The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: a new definition of remnant lipoproteins","volume":"461","author":"Sato","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2019.08.130_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2018.12.024","article-title":"LDL triglycerides, hepatic lipase activity, and coronary artery disease: an epidemiologic and Mendelian randomization study","volume":"282","author":"Silbernagel","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2019.08.130_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacc.2018.04.050","article-title":"Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease","volume":"72","author":"Saeed","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19316596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19316596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:39:48Z","timestamp":1757763588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19316596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0006291X19316596"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.130","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}